News

In this issue, Caring without Boundaries, you can find an in-depth look at our D&I strategy and our commitment to create an empowering workplace that guarantees real inclusion with equal opportunities.

Headway is a Mental Health initiative launched by The European House Ambrosetti and Angelini Pharma.

After the global communication campaign #ByMyEpilepside, Angelini Pharma adds a new chapter to the story about epilepsy.

The center opens today in Passoscuro, in Fiumicino’s municipality. It’s the first in Lazio Region and the largest in Italy for available places. Angelini Foundation among donors.

Angelini Pharma is providing its support to people affected by the ongoing humanitarian emergency.

On the occasion of International Epilepsy Day 2022, Angelini Pharma reaffirms its commitment to stay close to people with epilepsy launching its disease awareness and communications campaign: #ByMyEpilepside.

February 4th is the day dedicated worldwide to cancer awareness. Every year, the World Cancer Day promotes education, and actions against cancer to make prevention, treatment and care equitable for all.

Issued by the Top Employers Institute, this certification is awarded to all the companies that excel in their HR Practices and that create incentives for the development and well-being of their employees, guaranteeing the best working conditions.  

Angelini Pharma is pleased to announce the appointment of Rafal Kaminski as Chief Scientific Officer. He will join the Company on January 17th.

The National Institute for Health and Clinical Excellence (NICE) has published its final Technology Appraisal Guidance (TAG) for cenobamate.